Illumavista Nets $370K from NIH to Develop TF-Focused SNAP Array Platform | GenomeWeb

By Justin Petrone

The National Institutes of Health recently awarded Illumavista Biosciences $370,000 to develop a microarray platform for studying transcription factor binding.

Specifically, the Madison, Wis.-based firm received $150,000 to support a project entitled, "High-throughput method to assess SNP functionality in prostate cancer," and $268,168 to fund a second project, "Screening of FoxA1-ER-DNA disruptors for development of breast cancer therapeutic."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.